Our Founder and CEO Gianni De Fabritiis is attending the JP Morgan Healthcare Conference in San Francisco this week. Reach out to [email protected] if you would like to meet. #jpm2024 #drugdiscovery

Exciting News! 🚀 We've updated open.playmolecule.org with enhancements including: 🕜Reduced waiting time on viewer launch ⚡ Faster file loading 📊 Support for larger CSV tables 🔎 Options to filter table content 🖼️ Improved representation rendering Check it out now!

Acellera receives ISO 27001 certification in information security by DNV: acellera.com/blog/acellera-… #DrugDesign #DrugDiscovery #MolecularSimulation #AI #MachineLearning #healthcare

Our new molecular viewer has been published. Try it out here open.playmolecule.org

🚀 TorchMD-Net 2.0: Fast Neural Network Potentials for Molecular Simulations is here! 🚀 Paper: arxiv.org/abs/2402.17660 Repo: github.com/torchmd/torchm… Docs: torchmd-net.readthedocs.io A more versatile framework, with 2x-10x inference speedups for TensorNet 🧵👇

🎉Introducing QuantumBind®, our new platform for small-molecule discovery. In a recent publication, we showcase QuantumBind® RBFE module's performance vs industry leader FEP+ across several targets. Join our beta program & let's innovate together: acellera.webflow.io/blog/experimen…

🚀 ACEGEN by Acellera Therapeutics Our new toolkit for generative drug design that harnesses #ReinforcementLearning. Designed for robustness and efficiency, ACEGEN accelerates the discovery of desirable molecules. Learn more 👉 acellera.com/blog/acegen-a-… #DrugDiscovery #AI #Pharma

Discover how Acellera Tx is leveraging AI-driven drug discovery to deliver efficient target-to-hit insights within weeks, achieving a hit rate of over 10% across various target families with our cutting-edge technology. 📅 Book a meeting to learn more: login.partnering.bio.org/inova-business…

Trying to build nice graphics for a presentation? We are always working at improving the #PlayMolecule viewer. Try lnkd.in/dhVwfp7x.

Acellera's CEO Gianni De Fabritiis will give a lecture today on machine learning potentials at portal.ml4dd.com/summerschool

#ACEFORCE coming along nicely. Scan with the Aceforce DFT model on the Sellers torsion scan benchmark and we are still improving it.

We are thrilled to announce that Professor Andrew White (Andrew White 🐦‍⬛), an AI-driven drug discovery pioneer, has joined Acellera Therapeutics' Advisory Board. Welcome, Andrew! acellera.com/blog/prof-andr…

Gianni De Fabritiis is attending the L2M3 Workshop at CECAM-HQ in Lausanne! He'll showcase as well Acellera's work on applying chemical language models for chemistry. Stay tuned for insights and updates! #LLMs #Chemistry #Acellera #Innovation @CECAM_Org Gianni De Fabritiis

ACEGEN is now oficially published in JCIM & JCTC Journals. Check it out! ➡️ pubs.acs.org/doi/10.1021/ac…

ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug Discovery #DrugDiscovery pubs.acs.org/doi/10.1021/ac… Carles Navarro Maciej Majewski Gary Tresadern vmoens Gianni De Fabritiis Acellera Therapeutics #JCIM Vol64 Issue15 #MachineLearning #DeepLearning